Heart Failure Clinical Trial

Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients

Summary

The purpose of this study is to study the effects of tolvaptan on the size and function of the left heart chamber (ventricle) in patients with congestive heart failure (CHF)

View Eligibility Criteria

Eligibility Criteria

History of congestive heart failure

Study is for people with:

Heart Failure

Phase:

Phase 2

Estimated Enrollment:

170

Study ID:

NCT00043758

Recruitment Status:

Completed

Sponsor:

Otsuka Pharmaceutical Development & Commercialization, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 38 Locations for this study

See Locations Near You

Desert Cardiology of Tucson
Tucson Arizona, 85741, United States
Arkansas Heart
Little Rock Arkansas, 72211, United States
San Diego Cardiac Center
San Diego California, 92123, United States
Northern California Medical Associates
Santa Rosa California, 95403, United States
Cardiovascular Consultants Medical Group, Inc.
Walnut Creek California, 94598, United States
University of Colorado
Denver Colorado, 80262, United States
The Hoffman Heart Institute of CT/St. Francis Hospital
Hartford Connecticut, 06105, United States
Yale University
New Haven Connecticut, 06510, United States
Cardiology Associates of Fort Lauderdale
Fort Lauderdale Florida, 33308, United States
Cardiovascular Research Center of South Florida
Miami Florida, 33173, United States
Charlotte Heart Group
Port Charlotte Florida, 33952, United States
The Heart and Vascular Institute of Florida
St. Petersburg Florida, 33701, United States
Cardiovascular Associates of Augusta, PA
Augusta Georgia, 30901, United States
Georgia Heart Specialists
Covington Georgia, 30014, United States
Illinois Heart and Lung Associates, SC
Normal Illinois, 61761, United States
The Care Group, LLC
Indianapolis Indiana, 46260, United States
Medical Research Institute
Slidell Louisiana, 70458, United States
Androscoggin Cardiology Associates
Auburn Maine, 04210, United States
Maine Cardiology Associates
Portland Maine, 04102, United States
Pentucket Medical Associates
Haverhill Massachusetts, 01839, United States
Mystic Cardiology Associates, Inc.
Medford Massachusetts, 02155, United States
Harper Hospital/Wayne State University
Detroit Michigan, 48201, United States
John Dingell VA Medical Center
Detroit Michigan, 48201, United States
St. Luke's-Roosevelt Hospital Center
New York New York, 10025, United States
South Bay Cardiovascular Associates
West Islip New York, 11795, United States
The Lindner Clinical Trial Center
Cincinnati Ohio, 45219, United States
Midwest Cardiology Research Foundation
Columbus Ohio, 43202, United States
North Ohio Research LTD
Lorraine Ohio, 44053, United States
North Ohio Research LTD.
Sandusky Ohio, 44870, United States
Medical College of Pennsylvania
Philadelphia Pennsylvania, 19129, United States
Guthrie Clinic, LTD
Sayre Pennsylvania, 18840, United States
Miriam Hospital
Providence Rhode Island, 02905, United States
University Cardiology Foundation
Providence Rhode Island, 02905, United States
Ralph H. Johnson VAMC
Charleston South Carolina, 29401, United States
Stern Cardiovascular Center
Memphis Tennessee, 38120, United States
Health Sciences Center
Winnipeg Manitoba, R3A 1, Canada
Health Sciences Center Memorial University of Newfoundland
St. John's Newfoundland and Labrador, A1B 3, Canada
London Health Sciences Center
London Ontario, N6A 4, Canada
St. Michael's Hospital
Toronto Ontario, M5B 1, Canada
The Toronto Hospital
Toronto Ontario, M5G 2, Canada

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Phase:

Phase 2

Estimated Enrollment:

170

Study ID:

NCT00043758

Recruitment Status:

Completed

Sponsor:


Otsuka Pharmaceutical Development & Commercialization, Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider